- Home
- ABSI vs TOI Comparison
ABSI vs TOI Comparison
Compare ABSI & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | TOI |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.6M | 444.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABSI | TOI |
|---|---|---|
| Price | $3.18 | $3.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $7.78 | $6.00 |
| AVG Volume (30 Days) | ★ 4.6M | 3.1M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,815,000.00 | ★ $461,039,000.00 |
| Revenue This Year | $40.12 | $21.71 |
| Revenue Next Year | $331.37 | $20.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $2.01 | $0.15 |
| 52 Week High | $6.33 | $4.88 |
Technical Indicators
Market Signals| Indicator | ABSI | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 39.14 |
| Support Level | $2.71 | $2.88 |
| Resistance Level | $3.11 | $3.32 |
| Average True Range (ATR) | 0.24 | 0.35 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 59.91 | 19.12 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.